Stan Berenshteyn

Stock Analyst at Wells Fargo

(0.55)
# 2341
Out of 5,329 analysts
65
Total ratings
40.00%
Success rate
-5.95%
Average return
9 Stocks
Name Action PT Current % Upside Ratings Updated
GDRX GoodRx Holdings
Maintains: Overweight
8 7
4.76 47.06% 8 Apr 29, 2025
OMCL Omnicell
Maintains: Equal-Weight
40 38
31.86 19.27% 13 Apr 17, 2025
HQY HealthEquity
Maintains: Overweight
110 125
92.03 35.83% 9 Feb 26, 2025
DOCS Doximity
Maintains: Equal-Weight
43 55
59.58 -7.69% 10 Feb 7, 2025
HCAT Health Catalyst
Maintains: Overweight
13 10
4.18 139.23% 5 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
15 15
7.18 108.91% 3 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
275 285
235.91 20.81% 5 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 6
n/a n/a 10 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
28 23
7.09 224.4% 2 Mar 6, 2023